Sitalvi-M 50/500 (Sitagliptin/Metformin 50/500 mg)

Sitalvi-M 50/ 500 (Sitagliptin/ Metformin 50/ 500 mg)

Drug Form: Tablet

It is used to treat type 2 diabetes, which has only the following benefits than sitagliptin:

  1. Effective reduction of hemoglobin A1c by using the complementary effect of sitagliptin and metformin.
  2. Better control of blood glucose in comparison to metformin monotherapy.
  3. Specific reduction in hypoglycemic attacks (hypoglycemia) in diabetic patients.
  4. Weight loss similar to metformin monotherapy